All UAB investigators and staff involved in clinical trials, regardless of funding source, are required to meet the NIH policy regarding GCP training for basic GCP training and refresher GCP training ...
Many oral drugs show a high variability in pharmacokinetic exposure, and, for drugs with exposure related to efficacy, therapeutic drug monitoring can help optimize exposure in individual patients.
Hasan, Leucht et al. undertook a drug repurposing trial evaluating the mineralocorticoid antagonist spironolactone as a treatment for cognitive impairment in people with schizophrenia. The primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results